Literature DB >> 18494538

Tolerability of modern antidepressants.

George I Papakostas1.   

Abstract

Antidepressant side effects may have implications with regard to patient safety as well as the overall tolerability of treatment. Side effects relevant to patient safety can contribute to an increased risk of morbidity and mortality, but may or may not result in patient distress or discomfort. In contrast, side effects related to tolerability can contribute to patient discomfort but are not associated with an immediate increase in risk of morbidity or mortality. Common tolerability-related side effects of modern antidepressants include nausea, insomnia, somnolence, fatigue, sexual dysfunction, and weight gain. Because these side effects can result in patient discomfort and distress, they can lead to poor compliance or noncompliance with treatment that, in turn, may result in an increased risk of depressive relapse or recurrence. Modern antidepressants have varying tolerability profiles, and clinicians should be vigilant about balancing treatment efficacy with side effects when choosing antidepressants. This article compares the rates of common tolerability-related side effects among the newer (post-tricyclic era) antidepressants with the selective serotonin reuptake inhibitors, the most popular contemporary first-line treatment for depression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18494538

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  48 in total

Review 1.  Intervention in at-risk states for developing psychosis.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Andreas Bechdolf; Joachim Klosterkötter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-14       Impact factor: 5.270

Review 2.  Moving pharmacoepigenetics tools for depression toward clinical use.

Authors:  Laura M Hack; Gabriel R Fries; Harris A Eyre; Chad A Bousman; Ajeet B Singh; Joao Quevedo; Vineeth P John; Bernhard T Baune; Boadie W Dunlop
Journal:  J Affect Disord       Date:  2019-02-06       Impact factor: 4.839

Review 3.  A brief history of the development of antidepressant drugs: from monoamines to glutamate.

Authors:  Todd M Hillhouse; Joseph H Porter
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

Review 4.  Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease.

Authors:  Karen E Stewart; James L Levenson
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

Review 5.  A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2010-04-29       Impact factor: 7.616

Review 6.  Monoamine transporters: vulnerable and vital doorkeepers.

Authors:  Zhicheng Lin; Juan J Canales; Thröstur Björgvinsson; Morgane Thomsen; Hong Qu; Qing-Rong Liu; Gonzalo E Torres; S Barak Caine
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

7.  Psychometric evaluation of the Fatigue Severity Scale in patients with major depression.

Authors:  Panagiotis Ferentinos; Vassilis Kontaxakis; Beata Havaki-Kontaxaki; Dimitris Dikeos; Lefteris Lykouras
Journal:  Qual Life Res       Date:  2010-10-16       Impact factor: 4.147

8.  College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety, and depressive severity.

Authors:  Maren Nyer; David Mischoulon; Jonathan E Alpert; Daphne J Holt; Charlotte D Brill; Albert Yeung; Paola Pedrelli; Lee Baer; Christina Dording; Ilana Huz; Lauren Fisher; Maurizio Fava; Amy Farabaugh
Journal:  Ann Clin Psychiatry       Date:  2015-05       Impact factor: 1.567

Review 9.  Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Authors:  Natalie J Carter; Paul L McCormack
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  General medical with depression drugs associated.

Authors:  Donald Rogers; Ronald Pies
Journal:  Psychiatry (Edgmont)       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.